摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl (+/-)-(2R,3R)-2-bromo-3-hydroxy-5-phenylpentanoate

中文名称
——
中文别名
——
英文名称
ethyl (+/-)-(2R,3R)-2-bromo-3-hydroxy-5-phenylpentanoate
英文别名
(+/-)-erythro-2-bromo-3-hydroxy-5-phenyl-valeric acid ethyl ester;(+/-)-erythro-2-Brom-3-hydroxy-5-phenyl-valeriansaeure-aethylester;ethyl (2S,3S)-2-bromo-3-hydroxy-5-phenylpentanoate
ethyl (+/-)-(2R,3R)-2-bromo-3-hydroxy-5-phenylpentanoate化学式
CAS
——
化学式
C13H17BrO3
mdl
——
分子量
301.18
InChiKey
ALSWBHKQWDLWLG-RYUDHWBXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    17
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    ethyl (+/-)-(2R,3R)-2-bromo-3-hydroxy-5-phenylpentanoate 在 sodium azide 作用下, 以 二甲基亚砜 为溶剂, 以84%的产率得到ethyl (2R,3S)-2-azido-3-hydroxy-5-phenylpentanoate
    参考文献:
    名称:
    Novel derivatives of 4,4' dithiobis-(3-aminobutane-1-1-sulfonates) and compositions comprising the same
    摘要:
    本发明涉及公式(1)的4,4'-二硫基双(3-氨基丁烷-1-磺酸酯)的衍生物,用于治疗和预防原发性和继发性动脉高血压。
    公开号:
    US20060205695A1
  • 作为产物:
    描述:
    ethyl (2E)-5-phenylpent-2-enoatedibromamine-T 作用下, 以 乙腈 为溶剂, 反应 0.17h, 以86%的产率得到ethyl (+/-)-(2R,3R)-2-bromo-3-hydroxy-5-phenylpentanoate
    参考文献:
    名称:
    一种简单高效的方法,从烯烃中选择性合成立体溴代邻苯二酚和烷氧基溴化物
    摘要:
    已经开发了非常快速有效的方法,用于直接从烯烃合成邻位溴代醇和烷氧基溴化物,而无需任何催化剂。反应是在CH 3 CN-水(4:1)或酒精中,使用N,N-二溴-对甲苯甲苯磺酰胺(TsNBr 2)作为溴化剂进行的。已经获得了优异的产率以及区域选择性和立体选择性。溴代醇是瞬间形成的,而烷氧基溴化物的形成则需要30-60分钟。
    DOI:
    10.1021/jo0600611
点击查看最新优质反应信息

文献信息

  • The impact of gender, body dimension and body composition on hand-grip strength in healthy children
    作者:A. Sartorio、C. L. Lafortuna、S. Pogliaghi、L. Trecate
    DOI:10.1007/bf03344033
    日期:2002.5
    Maximum hand-grip (HG) strength, body composition and main anthropometric variables were evaluated in 278 children with normal weight and growth, aged 5-15 yr divided into 3 age groups: group 1, age+/-SD: 7.6+/-0.9 yr 7.6+/-0.9 SD (Tanner stage 1); group 2, age: 10.8+/-0.7 yr (Tanner stage: 2-3); group 3, age: 1 3.2+/-0.9 yr (Tanner stage: 4-5). Weight, height, body surface area (BSA), BMI, percent body fat (BF) and fat free mass (FFM) increased progressively and significantly from the younger to the older age group. A significant difference between genders was detected only for BF and FFM, females having a higher fat mass and a lower FFM compared to males. Most children were right-handed (91%). In either genders, a curvilinear relation was detected between HG strength and age, with best fit for the dominant (d) hand given by the equations: dHG=5.891 *10(0.051 age), r(2)=0.986, p<0.001 in males and dHG=6.163 *10(0.045 age), r(2)=0.973, p<0.001 in females. The increase in HG strength after 11 yr appears to be steeper in males as compared with that found in females. In both d and non-dominant (nd) hand, a significant difference in HG strength was detected between males and females, the average difference being about 10% at all ages. For both genders, nd hand was significantly weaker than d hand in the older age groups (2 and 3), but not in the younger group 1. Age and gender-dependent differences in HG strength (but not differences between d and nd hand) disappear if HG strength is normalized for FFM. Thus, in general, dHG strength normalized for FFM resulted on average to be 0.67+/-0.11 kg/kg. A multiple linear regression analysis indicated that HG was positively correlated with BMI, BSA, stature, stature(2) and FFM (p<0.001 for all correlations) without differences between genders, while a negative correlation was found between HG strength and %BF. The most significant correlation was found between HG strength and FFM, without any significant difference between genders, so that the overall equation describing the line for the d hand was: dHG strength = 2.32+0.63 FFM, r(2)=0.72, p<0.001. In conclusion, the present study indicates that the age-dependent increase of HG strength as well as the between-gender differences are strongly related to changes of FFM values occurring during childhood. Moreover, the study provides a standard normative value of maximal HG strength for the healthy children population in Northern Italy.
  • US7582797B2
    申请人:——
    公开号:US7582797B2
    公开(公告)日:2009-09-01
  • A Simple and Efficient Method for Regioselective and Stereoselective Synthesis of Vicinal Bromohydrins and Alkoxybromides from an Olefin
    作者:Prodeep Phukan、Pranita Chakraborty、Dolly Kataki
    DOI:10.1021/jo0600611
    日期:2006.9.1
    very rapid and efficient method has been developed for the synthesis of vicinal bromohydrins and alkoxybromides directly from an olefin without any catalyst. The reaction was performed in CH3CN−water (4:1) or alcohol using N,N-dibromo-p-toluenesulfonamide (TsNBr2) as the brominating agent. Excellent yields and regio- and stereoselectivities have been obtained. Bromohydrins are formed instantaneously
    已经开发了非常快速有效的方法,用于直接从烯烃合成邻位溴代醇和烷氧基溴化物,而无需任何催化剂。反应是在CH 3 CN-水(4:1)或酒精中,使用N,N-二溴-对甲苯甲苯磺酰胺(TsNBr 2)作为溴化剂进行的。已经获得了优异的产率以及区域选择性和立体选择性。溴代醇是瞬间形成的,而烷氧基溴化物的形成则需要30-60分钟。
  • Novel derivatives of 4,4' dithiobis-(3-aminobutane-1-1-sulfonates) and compositions comprising the same
    申请人:Roques Pierre Bernard
    公开号:US20060205695A1
    公开(公告)日:2006-09-14
    The invention relates to derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfonates) of formula (1), of use for the treatment and prevention of primary and secondary arterial hypertension.
    本发明涉及公式(1)的4,4'-二硫基双(3-氨基丁烷-1-磺酸酯)的衍生物,用于治疗和预防原发性和继发性动脉高血压。
查看更多